8.12
전일 마감가:
$8.61
열려 있는:
$8.7
하루 거래량:
1.27M
Relative Volume:
1.31
시가총액:
$720.06M
수익:
$73.48M
순이익/손실:
$-108.30M
주가수익비율:
-3.6089
EPS:
-2.25
순현금흐름:
$-67.17M
1주 성능:
+10.63%
1개월 성능:
+50.65%
6개월 성능:
+167.99%
1년 성능:
+64.37%
Personalis Inc Stock (PSNL) Company Profile
명칭
Personalis Inc
전화
650-752-1300
주소
6600 DUMBARTON CIRCLE, FREMONT, CA
PSNL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PSNL
Personalis Inc
|
8.12 | 763.51M | 73.48M | -108.30M | -67.17M | -2.25 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-15 | 개시 | Guggenheim | Buy |
2025-03-17 | 개시 | Craig Hallum | Buy |
2023-02-06 | 업그레이드 | Needham | Hold → Buy |
2022-01-07 | 업그레이드 | BofA Securities | Neutral → Buy |
2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-11-03 | 다운그레이드 | Needham | Buy → Hold |
2021-10-15 | 재개 | Cowen | Outperform |
2021-09-20 | 재확인 | Needham | Buy |
2021-05-06 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-01-28 | 개시 | Truist | Buy |
2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-11-12 | 재확인 | Needham | Buy |
2020-11-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-10-19 | 개시 | Citigroup | Buy |
2020-10-08 | 개시 | BTIG Research | Buy |
2020-08-27 | 개시 | H.C. Wainwright | Buy |
2020-08-18 | 개시 | Needham | Buy |
2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-07-15 | 개시 | BofA/Merrill | Neutral |
2019-07-15 | 개시 | Cowen | Outperform |
2019-07-15 | 개시 | Morgan Stanley | Overweight |
2019-07-15 | 개시 | Oppenheimer | Outperform |
모두보기
Personalis Inc 주식(PSNL)의 최신 뉴스
Analyzing net buyer seller activity in Personalis Inc.2025 Earnings Surprises & Verified Entry Point Signals - newser.com
How to monitor Personalis Inc. with trend dashboardsWeekly Market Outlook & Precise Buy Zone Tips - newser.com
Visual trend scoring systems applied to Personalis Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - newser.com
Forecasting Personalis Inc. price range with options dataEarnings Growth Report & Safe Capital Growth Plans - newser.com
Price momentum metrics for Personalis Inc. explained2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Understanding Personalis Inc.’s price movementPortfolio Return Report & Community Trade Idea Sharing - newser.com
What MACD signals say about Personalis Inc.Quarterly Trade Report & Weekly Momentum Picks - newser.com
Analyzing Personalis Inc. with risk reward ratio chartsDividend Hike & AI Optimized Trading Strategy Guides - newser.com
Head-To-Head Review: Parnell Pharmaceuticals (OTCMKTS:PARNF) versus Personalis (NASDAQ:PSNL) - Defense World
Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st
What analysts say about Personalis Inc 04X stockMarket Timing Techniques & Free Get High Impact Recommendations - earlytimes.in
Exit strategy if you’re trapped in Personalis Inc.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com
Why Personalis Inc. stock could be next big winner2025 Investor Takeaways & AI Driven Price Forecasts - newser.com
What indicators show strength in Personalis Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com
Will Personalis Inc. stock outperform tech sector in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Volume spikes in Personalis Inc. stock – what they meanJuly 2025 Action & Free Long-Term Investment Growth Plans - newser.com
What drives Personalis Inc stock priceSwing Trading Watchlist & Identify Winning Stocks - earlytimes.in
Goldman Sachs Group Inc. Has $998,000 Stock Position in Personalis, Inc. $PSNL - MarketBeat
Personalis (NASDAQ:PSNL) Trading 7.5% HigherHere's Why - MarketBeat
Acadian Asset Management LLC Reduces Position in Personalis, Inc. $PSNL - MarketBeat
Personalis (NASDAQ:PSNL) Upgraded to Hold at Wall Street Zen - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Receives $7.42 Consensus Price Target from Analysts - MarketBeat
Retail Trends: Is RPTX benefiting from interest rate changesOptions Play & Safe Capital Growth Plans - khodrobank.com
Should you hold or exit Personalis Inc. nowPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com
Aug Gainers: Will Freedom Holding Corp outperform small cap indexesRisk Management & Low Risk Growth Stock Ideas - khodrobank.com
What earnings revisions data tells us about Personalis Inc.2025 Key Lessons & High Accuracy Investment Signals - newser.com
How to track smart money flows in Personalis Inc.July 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
What data driven models say about Personalis Inc.’s futureTake Profit & Intraday High Probability Setup Alerts - newser.com
Income Plays: Whats the beta of Personalis Inc stockJuly 2025 Reactions & High Win Rate Trade Alerts - خودرو بانک
Identifying reversal signals in Personalis Inc.2025 Trading Recap & Reliable Breakout Stock Forecasts - newser.com
Personalis Inc (PSNL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Personalis Inc 주식 (PSNL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
자본화:
|
볼륨(24시간):